tldrdaily.news logo
Tag

Danuglipron

All articles tagged with #danuglipron

health2 years ago

Pfizer's Weight Loss Pill Canceled Due to Serious Side Effects

Pfizer has announced the discontinuation of clinical trials for its weight loss pill, danuglipron, due to high rates of gastrointestinal side effects experienced by patients. The pill, which uses a similar mechanism to semaglutide, resulted in adverse events such as nausea, vomiting, and diarrhea in a large percentage of participants. Despite this setback, Pfizer remains committed to developing a weight loss pill and will continue to explore potential improvements in tolerability and study design. The news of the side effects caused a four percent drop in Pfizer's stock.

via Futurism|
#clinical-trials#danuglipron#health
health2 years ago

Pfizer Abandons Weight Loss Pill Due to Adverse Effects

Pfizer has decided to abandon a twice-daily obesity treatment after more than half of the patients in a clinical trial stopped taking it due to nausea and vomiting. The pharmaceutical company will instead focus on a once-daily version of the pill, danuglipron. While the mid-stage study showed statistically significant weight loss in adults with obesity, the discontinuation rates and side effects were concerning. Pfizer's decision comes as obesity treatments continue to be a lucrative area of medicine, with rivals Novo Nordisk and Eli Lilly already having injectable drugs on the market.

via ABC News|
#clinical-trial#danuglipron#health
pharmaceuticals2 years ago

"Pfizer's Weight Loss Drug Ambitions Hinge on Upcoming Data"

Pfizer is aiming to enter the weight loss drug market with its experimental obesity pill, danuglipron, and upcoming data from phase two trials will be crucial in determining its competitiveness against dominant players Eli Lilly and Novo Nordisk. Investors are eagerly awaiting the trial results, hoping to see similar levels of weight loss as Eli Lilly's once-daily pill. Pfizer sees a major opportunity in the weight loss drug segment and aims to capture a significant portion of the market with an oral treatment. The success of Pfizer's data could help boost its share prices and provide relief from the decline caused by the drop in demand for its Covid products.

via CNBC|
#clinical-trials#danuglipron#obesity